tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Clearmind Medicine regains Nasdaq compliance
PremiumThe FlyClearmind Medicine regains Nasdaq compliance
16d ago
Psychedelic: Atai Beckley granted U.S. patent for EMP-01
Premium
The Fly
Psychedelic: Atai Beckley granted U.S. patent for EMP-01
17d ago
Psychedelic: Clearmind reports CMND-100 dosing at Hadassah Medical Center
Premium
The Fly
Psychedelic: Clearmind reports CMND-100 dosing at Hadassah Medical Center
24d ago
Clearmind says DSMB approves continuation of Phase I/IIa trial of CMND-100
PremiumThe FlyClearmind says DSMB approves continuation of Phase I/IIa trial of CMND-100
1M ago
Psychedelic: Clearmind reports results from first cohort in AUD trial
Premium
The Fly
Psychedelic: Clearmind reports results from first cohort in AUD trial
1M ago
SciSparc, Clearmind Medicine file Israeli patent application for depression
Premium
The Fly
SciSparc, Clearmind Medicine file Israeli patent application for depression
1M ago
Clearmind Medicine receives final approval to expand Phase 1/2a AUD trial
PremiumThe FlyClearmind Medicine receives final approval to expand Phase 1/2a AUD trial
2M ago
Clearmind announces notice of publication of patent for MEAI in China
Premium
The Fly
Clearmind announces notice of publication of patent for MEAI in China
2M ago
Clearmind Medicine completes first cohort treatment in Phase I/IIa AUD trial
Premium
The Fly
Clearmind Medicine completes first cohort treatment in Phase I/IIa AUD trial
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100